The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor-positive/progesterone receptor-negative/Her-2/neu receptor-positive pattern

Am J Surg. 2007 Aug;194(2):272-3. doi: 10.1016/j.amjsurg.2006.07.022.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aromatase Inhibitors / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology
  • Carcinoma, Intraductal, Noninfiltrating / drug therapy*
  • Carcinoma, Intraductal, Noninfiltrating / metabolism*
  • Carcinoma, Intraductal, Noninfiltrating / pathology
  • Female
  • Humans
  • Neoplasm Recurrence, Local / prevention & control*
  • Postmenopause
  • Receptor, ErbB-2 / metabolism
  • Receptors, Estrogen / metabolism
  • Receptors, Progesterone / metabolism

Substances

  • Aromatase Inhibitors
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Receptor, ErbB-2